Table 2.

NK and T cells in donors and recipients at day +100 after UBM or TCD transplantation




All

UBM

TCD

P (UBM vs TCD)
No. patients   77   37   40   
CD56+/CD3- cells     
   Donor, %   9.80 ± 0.71   10.71 ± 1.14   8.99 ± 0.86   .23  
   Recipient, %   40.16 ± 2.60   37.12 ± 3.57   42.98 ± 3.73   .26  
   P, donor vs. recipient   < .001   < .001   < .001   
CD56-/CD3+ cells     
   Donor, %   62.47 ± 1.28   61.08 ± 2.08   63.72 ± 1.55   .31  
   Recipient, %   28.61 ± 1.28   36.01 ± 3.62   21.76 ± 2.95   .003  
   P, donor vs. recipient   < .001   < .001   < .001   
CD56+/CD3+ cells     
   Donor, %   4.01 ± 0.42   4.16 ± 0.67   3.88 ± 0.52   .74  
   Recipient, %   3.20 ± 0.47   3.17 ± 0.61   3.22 ± 0.73   .96  
   P, donor vs. recipient
 
.20
 
.21
 
.41
 

 



All

UBM

TCD

P (UBM vs TCD)
No. patients   77   37   40   
CD56+/CD3- cells     
   Donor, %   9.80 ± 0.71   10.71 ± 1.14   8.99 ± 0.86   .23  
   Recipient, %   40.16 ± 2.60   37.12 ± 3.57   42.98 ± 3.73   .26  
   P, donor vs. recipient   < .001   < .001   < .001   
CD56-/CD3+ cells     
   Donor, %   62.47 ± 1.28   61.08 ± 2.08   63.72 ± 1.55   .31  
   Recipient, %   28.61 ± 1.28   36.01 ± 3.62   21.76 ± 2.95   .003  
   P, donor vs. recipient   < .001   < .001   < .001   
CD56+/CD3+ cells     
   Donor, %   4.01 ± 0.42   4.16 ± 0.67   3.88 ± 0.52   .74  
   Recipient, %   3.20 ± 0.47   3.17 ± 0.61   3.22 ± 0.73   .96  
   P, donor vs. recipient
 
.20
 
.21
 
.41
 

 

All percentage values are mean ± SEM.